Inflammatory bowel disease prognostics

Details for Australian Patent Application No. 2010236568 (hide)

Owner Prometheus Laboratories Inc.

Inventors Barken, Derren; Princen, Fred; Eggleston, Leonard; Singh, Sharat

Agent Watermark

Pub. Number AU-A-2010236568

PCT Pub. Number WO2010/120814

Priority 61/300,787 02.02.10 US; 61/265,324 30.11.09 US; 61/265,723 01.12.09 US; 61/302,066 05.02.10 US; 61/169,230 14.04.09 US; 61/220,453 25.06.09 US; 61/286,356 14.12.09 US; 61/255,066 26.10.09 US; 61/262,903 19.11.09 US; 61/178,454 14.05.09 US

Filing date 13 April 2010

Wipo publication date 21 October 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/120814 Priority application(s): WO2010/120814

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236572-Ensemble-decision aliquot ranking

2010236563-Conducting lines, nanoparticles, inks, and patterning